GSK
Price
$40.80
Change
+$0.34 (+0.84%)
Updated
Jun 4 closing price
Capitalization
88.13B
55 days until earnings call
JNJ
Price
$153.22
Change
-$1.20 (-0.78%)
Updated
Jun 4 closing price
Capitalization
380.22B
41 days until earnings call
Interact to see
Advertisement

GSK vs JNJ

Header iconGSK vs JNJ Comparison
Open Charts GSK vs JNJBanner chart's image
GSK
Price$40.80
Change+$0.34 (+0.84%)
Volume$2.94M
Capitalization88.13B
Johnson & Johnson
Price$153.22
Change-$1.20 (-0.78%)
Volume$6.98M
Capitalization380.22B
GSK vs JNJ Comparison Chart
Loading...
GSK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GSK vs. JNJ commentary
Jun 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSK is a Buy and JNJ is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 05, 2025
Stock price -- (GSK: $40.80 vs. JNJ: $153.22)
Brand notoriety: GSK: Not notable vs. JNJ: Notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: GSK: 52% vs. JNJ: 75%
Market capitalization -- GSK: $88.13B vs. JNJ: $380.22B
GSK [@Pharmaceuticals: Major] is valued at $88.13B. JNJ’s [@Pharmaceuticals: Major] market capitalization is $380.22B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GSK’s FA Score shows that 2 FA rating(s) are green whileJNJ’s FA Score has 2 green FA rating(s).

  • GSK’s FA Score: 2 green, 3 red.
  • JNJ’s FA Score: 2 green, 3 red.
According to our system of comparison, GSK is a better buy in the long-term than JNJ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GSK’s TA Score shows that 6 TA indicator(s) are bullish while JNJ’s TA Score has 5 bullish TA indicator(s).

  • GSK’s TA Score: 6 bullish, 3 bearish.
  • JNJ’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, GSK is a better buy in the short-term than JNJ.

Price Growth

GSK (@Pharmaceuticals: Major) experienced а +4.13% price change this week, while JNJ (@Pharmaceuticals: Major) price change was -0.02% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +3.27%. For the same industry, the average monthly price growth was +2.61%, and the average quarterly price growth was +3.54%.

Reported Earning Dates

GSK is expected to report earnings on Jul 30, 2025.

JNJ is expected to report earnings on Jul 16, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+3.27% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JNJ($380B) has a higher market cap than GSK($88.1B). JNJ has higher P/E ratio than GSK: JNJ (30.34) vs GSK (14.01). GSK YTD gains are higher at: 23.370 vs. JNJ (7.710). JNJ has higher annual earnings (EBITDA): 23.3B vs. GSK (9.08B). JNJ has more cash in the bank: 22.9B vs. GSK (4.99B). GSK has less debt than JNJ: GSK (18B) vs JNJ (29.3B). JNJ has higher revenues than GSK: JNJ (85.2B) vs GSK (30.3B).
GSKJNJGSK / JNJ
Capitalization88.1B380B23%
EBITDA9.08B23.3B39%
Gain YTD23.3707.710303%
P/E Ratio14.0130.3446%
Revenue30.3B85.2B36%
Total Cash4.99B22.9B22%
Total Debt18B29.3B61%
FUNDAMENTALS RATINGS
GSK vs JNJ: Fundamental Ratings
GSK
JNJ
OUTLOOK RATING
1..100
127
VALUATION
overvalued / fair valued / undervalued
1..100
10
Undervalued
15
Undervalued
PROFIT vs RISK RATING
1..100
6147
SMR RATING
1..100
4133
PRICE GROWTH RATING
1..100
4755
P/E GROWTH RATING
1..100
1978
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GSK's Valuation (10) in the Pharmaceuticals Major industry is in the same range as JNJ (15). This means that GSK’s stock grew similarly to JNJ’s over the last 12 months.

JNJ's Profit vs Risk Rating (47) in the Pharmaceuticals Major industry is in the same range as GSK (61). This means that JNJ’s stock grew similarly to GSK’s over the last 12 months.

JNJ's SMR Rating (33) in the Pharmaceuticals Major industry is in the same range as GSK (41). This means that JNJ’s stock grew similarly to GSK’s over the last 12 months.

GSK's Price Growth Rating (47) in the Pharmaceuticals Major industry is in the same range as JNJ (55). This means that GSK’s stock grew similarly to JNJ’s over the last 12 months.

GSK's P/E Growth Rating (19) in the Pharmaceuticals Major industry is somewhat better than the same rating for JNJ (78). This means that GSK’s stock grew somewhat faster than JNJ’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GSKJNJ
RSI
ODDS (%)
Bearish Trend 1 day ago
49%
Bullish Trend 1 day ago
49%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
47%
Bearish Trend 1 day ago
42%
Momentum
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 1 day ago
38%
MACD
ODDS (%)
Bullish Trend 1 day ago
58%
Bullish Trend 1 day ago
32%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
57%
Bearish Trend 1 day ago
43%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
51%
Bearish Trend 1 day ago
43%
Advances
ODDS (%)
Bullish Trend 4 days ago
57%
Bullish Trend 4 days ago
40%
Declines
ODDS (%)
Bearish Trend 23 days ago
53%
Bearish Trend 1 day ago
43%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
48%
Aroon
ODDS (%)
Bullish Trend 1 day ago
53%
Bearish Trend 1 day ago
35%
View a ticker or compare two or three
Interact to see
Advertisement
GSK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PXLW0.510.04
+8.56%
Pixelworks
LX7.420.35
+4.95%
LexinFintech Holdings Ltd
BKD6.620.02
+0.30%
Brookdale Senior Living
GEHC71.13-0.03
-0.04%
GE HealthCare Technologies
SLM32.18-0.49
-1.50%
SLM Corp

GSK and

Correlation & Price change

A.I.dvisor indicates that over the last year, GSK has been loosely correlated with NVS. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if GSK jumps, then NVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GSK
1D Price
Change %
GSK100%
+0.84%
NVS - GSK
61%
Loosely correlated
+0.86%
AZN - GSK
54%
Loosely correlated
+1.64%
PFE - GSK
53%
Loosely correlated
+0.17%
AMGN - GSK
50%
Loosely correlated
-0.88%
SNY - GSK
47%
Loosely correlated
+0.63%
More

JNJ and

Correlation & Price change

A.I.dvisor indicates that over the last year, JNJ has been loosely correlated with PFE. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if JNJ jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JNJ
1D Price
Change %
JNJ100%
-0.78%
PFE - JNJ
59%
Loosely correlated
+0.17%
NVS - JNJ
54%
Loosely correlated
+0.86%
GSK - JNJ
46%
Loosely correlated
+0.84%
AMGN - JNJ
44%
Loosely correlated
-0.88%
ABBV - JNJ
44%
Loosely correlated
+0.05%
More